Empliciti side effects by duration, gender and age - a phase IV clinical study of FDA data
Summary:
Side effects are reported by people who take Empliciti. Common side effects include death among females and death among males.
The phase IV clinical study is created by eHealthMe based on 2,234 reports from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
2,234 people who take Empliciti and have side effects are studied.
What is Empliciti?
Empliciti has active ingredients of elotuzumab. eHealthMe is studying from 2,236 Empliciti users for its effectiveness, alternative drugs and more.
Number of Empliciti reports submitted per year:
Empliciti side effects by time on the drug *:
Empliciti side effects by gender *:
Empliciti side effects by age *:
* Approximation only. Some reports may have incomplete information.
Do you take Empliciti?
Personalize this study to your gender and ageHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How the study uses the data?
The study is based on elotuzumab (the active ingredients of Empliciti) and Empliciti (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered.
Related studies
Alternative drugs to, pros and cons of Empliciti:
- Empliciti (2,236 reports)
Common Empliciti side effects:
- Death: 203 reports
- Fatigue (feeling of tiredness): 142 reports
- Diarrhea: 126 reports
- Multiple myeloma (cancer of the plasma cells): 121 reports
All Empliciti side effects from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zWho is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Plavix and Neuropathy Peripheral - a second ago
- Menstruation Irregular and Injection Site Swelling - 11 seconds ago
- Lorbrena and Flatulence - 14 seconds ago
- Besponsa and Thrombocytopenia - 14 seconds ago
- Plavix and Nasopharyngitis - 15 seconds ago
- Entresto and Dry Mouth - 15 seconds ago
- Ganciclovir and Cataract - 23 seconds ago
- Plavix and Drug Hypersensitivity - 34 seconds ago
- Phrenilin Forte and Irritability - 39 seconds ago
- Oxycodone And Acetaminophen and Organising Pneumonia - 40 seconds ago